FDA Inspection 1007862 — Dxn Pharmaceutical Sdn Bhd
The FDA completed an inspection of Dxn Pharmaceutical Sdn Bhd on March 16, 2017 in Jitra. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Food/Cosmetics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- March 16, 2017
- Fiscal Year
- 2017
- Product Type
- Food/Cosmetics
- Project Area
- Food Composition, Standards, Labeling and Econ
- Location
- Jitra (Malaysia)